Clinical Trials Directory

Trials / Completed

CompletedNCT00476892

Multi-centre Randomised Controlled Trial of Pelvic Floor Muscle Training for Prolapse

A Multi-centre Randomised Controlled Trial of a Pelvic Floor Muscle Training Intervention for Women With Pelvic Organ Prolapse

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
448 (actual)
Sponsor
Glasgow Caledonian University · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine the effectiveness and cost-effectiveness of pelvic floor muscle training in the management of pelvic organ prolapse in women.

Detailed description

Pelvic organ prolapse is a common problem that adversely affects the daily activities and quality of life of many women. Pelvic floor muscle training interventions are commonly used by physiotherapists to manage prolapse. However, a Cochrane review found limited evidence to support the effectiveness of such interventions. Based on the findings of a successful feasibility study, this multi-centre randomised controlled trial will address the paucity of evidence. 556 symptomatic women with diagnosed prolapse will be enrolled in 16 UK centres and 1 New Zealand centre over 16 months and randomised to pelvic floor muscle training plus lifestyle advice, or to receive a lifestyle leaflet only. Principal measures of outcome are: prolapse symptoms, prolapse severity, and subsequent further treatment up to 12 months after trial entry.

Conditions

Interventions

TypeNameDescription
PROCEDUREPelvic Floor Muscle TrainingWomen in the intervention group attend 5 physiotherapy sessions. At each appointment a clinical history is taken, pelvic floor muscle assessment carried out, exercises taught and prescribed, and appropriate lifestyle advice given. At the first of these appointments a detailed explanation of the pelvic anatomy and different types of prolapse is given.

Timeline

Start date
2007-06-01
Primary completion
2010-07-01
Completion
2011-03-01
First posted
2007-05-22
Last updated
2011-03-23

Locations

28 sites across 4 countries: Australia, Ireland, New Zealand, United Kingdom

Source: ClinicalTrials.gov record NCT00476892. Inclusion in this directory is not an endorsement.